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B or beta cells the cells in the islets of Langerhans in the pancreas that produce insulin. 
diabetes mellitus a heterogeneous group of disorders, characterised by hyperglycaemia, and 
disturbances of carbohydrate, fat and protein metabolism which are associated with absolute 
or relative deficiencies of insulin secretion and/or insulin action. 
glycosuria sugar in the urine. 
hyperglycaemia excessive levels of glucose in the blood. This is a feature of untreated or 
undertreated diabetes mellitus. 
hypoglycaemia abnormally low levels of glucose in the blood. Symptoms are idiosyncratic 
but may include trembling, faintness, sweating, palpitations, mental confusion, slurred 
speech, headache, loss of memory and double vision. Sever, untreated hypoglycaemia may 
lead to fits or coma and on rare occasions, death. It can be caused by an overdose of insulin. 
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islet cell antibodies (ICAs) antibodies which are present in the blood when the body 
develops an autoimmune reaction to the pancreatic islet cells. The presence of ICAs indicates 
that the process of destruction has started which will eventually lead to Type 1 diabetes. This 
process appears to take at least 7 years before diabetes is clinically manifested. 
insulin a peptide hormone produced in the beta cells of the Islets of Langerhans in the 
pancreas. Insulin facilitates and accelerates the movement of glucose and amino acids across 
cell membranes. It also controls the activity of certain enzymes within the cells concerned 
with carbohydrate, fat and protein metabolism. 
 
TYPE 1 DIABETES MELLITUS, also known as insulin-dependent diabetes mellitus 
(IDDM), juvenile-onset diabetes, or ketosis-prone diabetes, is the commonest form of 
diabetes to occur in children and young adults of European origin. Age at clinical onset of the 
condition is usually under the age of 40 years and often under 30 years. People who have 
Type 1 diabetes lose the ability to produce insulin. Exogenous insulin, usually delivered by 
injection, will be needed continuously throughout the lifetime of a person with Type 1 
diabetes with the possible exception of a brief honeymoon period which may occur within a 
year of clinical onset when endogenous insulin production is temporarily restarted. The onset 
of Type 1 diabetes is abrupt with severe thirst, excessive urination and dramatic weight loss. 
Individuals usually present to the doctor with one or more of these symptoms and an elevated 
blood glucose level.  
Once developed, IDDM can be managed by balancing a combination of insulin injections, 
intake of carbohydrates in the diet, and energy expenditure. The goal of treatment is to 
maintain blood glucose levels as close to the normal range as possible in order to reduce the 
risk of chronic complications while also avoiding the dangers of blood glucose falling to 
hypoglycaemic levels. 
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I.  Stress and Type 1 Diabetes Onset 
Although it has not been possible to determine the exact pathogenesis involved in the 
expression of Type 1 diabetes, it is clear that genetics play an important role.  The genetic 
component of the condition is indicated by the increased prevalence of IDDM in first degree 
relatives of 5% compared with less than 1% in the general population.  However, genetic 
susceptibility is not sufficient to cause diabetes since a majority of  people with disease-
associated alleles do not develop IDDM. Environmental factors also play an important role in 
the overt expression of Type 1 diabetes, although the mechanisms are still unclear. 
Psychological stress may also have a role in increasing vulnerability to viral infection or 
impairing defence mechanisms against infection, thereby facilitating the progression of the 
hidden pathological process. For example, stress-related changes in immune function may 
increase the likelihood of viral or bacterial disease, which may provide the initial insult to the 
B (or beta) cells. A second mechanism whereby stress may be implicated in diabetes onset 
may occur around the time when diabetes becomes symptomatic. Stress-related counter-
regulatory hormone activity may aggravate the metabolic disturbance that has already 
developed. In fact, if the already elevated blood glucose level increases to beyond the renal 
threshold, glycosuria will cause dehydration which may then produce the first symptoms of 
overt diabetes. Many anecdotal accounts and descriptive reports of life stresses occurring 
synonymously with symptomatic Type 1 diabetes onset may reflect this second mechanism 
where stress triggers overt manifestation of symptoms. 
A. Animal Studies 
It has been shown that stress may be associated with the onset of Type 1 diabetes in the 
genetic model for this type of diabetes. In the diabetes-prone BB Wistar rat, thirty to seventy 
percent of these animals have impaired glucose tolerance with hypo-insulinemia and 
hyperglycaemia by 150 days of age. It has been shown that these rats developed diabetes 
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earlier, when exposed to restraint and crowding. It has also been found in the BB rat, that 
chronic stress significantly increases the incidence of phenotypic expression of the gene for 
Type 1 diabetes. Eighty percent of the stressed males and 70% of the stressed female animals 
developed diabetes, compared with 50% in both control groups. However, because of the 
range of additional immune and endocrinological abnormalities evident in the BB rats, 
generalizability of these findings to humans are limited. 
B. Human Studies 
Research has shown that people who go on to develop Type 1 diabetes are more likely to 
suffer a major family loss or an increase in other stressful life events before diagnosis. Some 
of these studies have been poorly controlled and were also prone to recall bias, where the 
pattern of life events reported may reflect an attempt to find an explanation for diabetes onset 
rather than a difference in the events actually encountered.  However, a more carefully 
controlled study of life events which avoided problems of recall bias has also shown that 
people with diabetes had significantly more severe life events within the 3 years before 
diagnosis than either non-diabetic siblings or matched controls (Robinson and Fuller, 1985). 
It is possible that life events experienced over longer time periods may play a role in the 
aetiology of Type 1 diabetes. It is clear from prospective studies of ICAs that many years 
may elapse between the actions of the possible stress-related causal agents to initiate cell 
damage and the symptomatic diabetes to appear. 
Clear evidence of the effect of stress on diabetes onset is difficult to establish. It has not been 
thoroughly investigated in recent years, probably due to the methodological problems and 
interpretation of the findings which would involve expensive large prospective studies or 
reliance on retrospective methods to identify the relationship between stressful periods and 
the onset of the disease.  On the other hand, researchers have given increased attention to the 
relationship between stress and diabetes control. 
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II. Stress and Type 1 Diabetes Control 
It is widely recognised among people with diabetes and their clinicians that psychological 
stress can impair glycaemic control. Theoretically, stress-related hyperglycaemia should be 
greater in Type 1 patients (compared to Type 2 patients) because Type 1 patients have little 
or no endogenous insulin to offset increased blood glucose levels. Stress may affect diabetes 
control in at least two ways: 
i)  a direct psychophysiological effect via sympathetic and pituitary activity resulting in the 
elevation of catabolic hormone levels and the suppression of anabolic hormones. In people 
with diabetes, this may result in increased blood glucose levels, although, for a small 
minority, less readily understood decreases in blood glucose levels result. 
ii)  a behavioural mechanism whereby stress leads to behavioural changes capable or 
disrupting self-care behaviour. For example, the occurrence of unexpected, frustrating 
events may disrupt the diabetes self-care routines.  
A. Acute Stress and Blood Glucose Control 
Pioneering work examining the relationship between stress and diabetes was most often 
conducted in the laboratory, and the stresses induced were normally acute. Early research by 
Hinkle and others in the early 1950s, induced stress in some of their patients by a psychiatric 
interview and found changes in their blood ketone levels that remitted when the stress was 
removed. These researchers carried out a series of studies which showed that both individuals 
without diabetes and individuals with diabetes (both Type 1 and Type 2 patients were 
studied) have a metabolic response to psychological stress which included changes in urine 
glucose, blood glucose and blood ketones, but the response of those with diabetes was 
greater. Research in the 1960s included investigations of stress under hypnosis and 
examination stress, which resulted in a decrease in blood glucose levels. However, early 
studies have been criticised on methodological and conceptual grounds. There was concern 
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that the stressors used were not sufficiently potent or reproducible. Furthermore, the grouping 
together of heterogeneous patients with Type 1 and 2 diabetes and those with different 
degrees of blood glucose control in studies or very small groups were also a focus of 
criticism.  
Several seemingly well-controlled acute stress studies conducted in the 1980s reported no 
significant changes in blood glucose control in response to potential stressors such as mental 
arithmetic and public speaking. However, in an attempt to meet the criticisms levelled at the 
earlier studies, these later studies have overlooked the possibility that individual differences 
in response to stress might be real and interesting and not a reflection of methodological 
inadequacies. More recent studies of experimental stress have examined physiological 
mechanisms hypothesised to mediate the relationship between stress and blood glucose 
control. There is evidence that reduced blood flow to the insulin injection site and insulin 
resistance over several hours may cause increased blood glucose levels in individuals with 
Type 1 diabetes in response to acute laboratory stressors. There is also evidence that the level 
of blood glucose rises in some patients, and falls in others in response to a laboratory stressor 
(Stroop test), and that these changes can be largely explicable in terms of changes in 
injection-site blood flow. Vasodilation at the subcutaneous insulin injection site may in some 
cases lead to a paradoxical hypoglycaemic effect during acute stress via an increased rate of 
absorption of insulin, an effect which will be counterbalanced to a greater or lesser degree by 
increases in counter-regulatory hormones. More commonly, absorption of insulin may fall 
during stress as a result of vasoconstriction and reduced skin blood flow and contribute to 
hyperglycaemia.  
Idiosyncratic blood glucose responses which were reliable across a 12-week time period 
within individuals with Type 1 diabetes have been reported in response to caffeine and to the 
competitive playing of a video game. Researchers have therefore begun to consider 
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individual differences in response to stress to be real and interesting and not a reflection of 
methodological inadequacies. The inconsistent findings of previous research may have arisen 
at least in part because of differences in the stress-responsiveness of the individual patients 
recruited. 
B. Life Stress and Diabetes Control 
1. Major life events  
Studies of major life events and diabetes control have produced fairly consistent results 
which have suggested that increased life events (over past several months to a year) are 
associated with raised blood glucose levels, usually measured by Glycosylated Haemoglobin 
(GHb) or the related measure of haemoglobin A1 (HbA1) and haemoglobin A1c (HbA1c). 
These measures reflect average blood glucose levels over the previous six to eight weeks. In 
some studies, more life events were reported by groups showing a stronger association 
between life events and HbA1c levels. This could be due to a perceptual bias which may have 
lead people who experienced greater disturbance in association with life events to be more 
likely to recall the occurrence of life events. It could be that the subgroups did not actually 
differ in the number of life events reported, but only in their recollection of the events. 
However, a two-way causal link in which life events cause disruptions in diabetes control, 
which in turn cause increased life events has been suggested (Bradley, 1988). There is 
evidence that glycaemic fluctuations themselves can contribute to behavioural changes. It is 
now well-established that both hypo- and hyperglycaemia can impair cognitive functioning. 
Cognitive impairment may in turn cause inadvertent behavioural changes (e.g. in poor self-
care responses to feedback from blood glucose monitoring) which can affect blood glucose 
control. Poorly controlled diabetes may also result in mood changes causing interpersonal 
conflict and thereby increasing stress levels and associated physiological reactivity. Physical 
symptoms are also caused by extreme blood glucose levels, e.g. fatigue is often associated 
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with high blood glucose levels. Hypoglycaemic comas may have many consequences 
including accidents, job loss, and relationship problems. These relationships are described in 
the stress-blood glucose model shown in Figure 1. 
The practice of aggregating life stresses and blood glucose levels across time, incorporated 
by the majority of the life event studies, assumes minimal within-individual variation in 
stress and in blood glucose response. Such assumptions are not supported by common 
experience or by the literature which suggests that stress experienced varies within 
individuals from day to day. Information about the variability of blood glucose levels is lost 
when measures of GHb are used which give only an average of blood glucose control.  
Hypoglycaemia is not reflected in GHb measures because of its transient nature either. 
Multiple observations of stress are required together with serial blood glucose measurement. 
Recent research has focused on the relationship between minor daily events and diabetes 
control (using serial blood glucose measurements) in order to overcome these methodological 
limitations. 
2. Minor daily events 
Investigations of minor events have provided more interpretable results with studies 
reflecting individual differences to stress that were also seen in some of the laboratory-based 
acute stress studies. Although the overall picture suggests that increased daily stress 
correlates with increased blood glucose levels in people with Type 1 diabetes, examination of 
individual’s blood glucose response to stress indicates that some people display blood 
glucose reactivity to stress and some people do not. In one study, approximately half the 
sample of 15 participants with Type 1 diabetes had significant associations between stress 
and blood glucose levels, and this association was independent of the effects of diet and 
exercise self-management (Halford et al., 1990). Within those people who display stress-
reactivity, most show an increase in blood glucose but there is also evidence to suggest that a 
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smaller proportion of people show a decrease in blood glucose. Therefore, in order for people 
with Type 1 diabetes to take appropriate action to prevent or correct stress-related disruptions 
in diabetes control, they need to discover empirically how their own blood glucose levels 
respond to different kinds of stress.  
C. Investigation of correlates of stress-reactivity 
There is some evidence to suggest that people with poor control of their diabetes may be 
more stress-reactive (stress being measured by either laboratory-based or life events). This 
supports the model in Figure 1. There is also evidence that children with Type 1 diabetes who 
are classified as having Type A personality characteristics show elevated blood glucose 
levels after playing a stressful video game, whereas Type B children with Type 1 diabetes 
showed a decrease in blood glucose levels (Stabler, 1986). However, there is also evidence 
that internality and self-esteem did not relate to stress-reactivity in the group of women with 
Type 1 diabetes studied (Aikens et al., 1994). It is likely that individual differences in stress 
response are mediated by both physiological and psychological processes, however further 
research is necessary to identify the variables associated with stress-reactivity.  
III. Stress Management Training and Type 1 Diabetes Control 
The overly simple model of life stress causing raised blood glucose levels has inspired the 
use of stress management training, particularly relaxation training, as an aid to diabetes 
control. Relaxation is thought to decrease the levels of both cortisol and catecholamines, and 
hence is expected to prevent stress-induced increases in blood glucose levels. 
The research to date supports the view that stress management techniques may be valuable to 
aid diabetes management for some people but not for others. It has been suggested that 
relaxation techniques are unlikely to do harm except when blood glucose in already tightly 
controlled and the insulin dosage is not appropriately reduced to balance the effects of 
relaxation on insulin requirements (which may well be reduced) and/or when used at a time 
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when blood glucose is already low (<4 mmol/l) and there is a risk of hypoglycaemia. It is 
important to take the precaution of measuring blood glucose immediately before all 
relaxation training or practice sessions. Twenty minutes of relaxation can lead to a drop in 
blood glucose by as much as 3 mmol/l. Such a substantial fall is only likely if blood glucose 
is well above the normal range of 4-6 mmol/l to start with and probably results from a 
suppression of catecholamine secretion. It is recommended that relaxation training should not 
be conducted at blood glucose levels below 4 mmol/l because of the risk of hypoglycaemia. 
Relaxation training might be continued if the anticipated reduction in blood glucose were 
counteracted with pre-training intake of slow release carbohydrate (e.g. an apple). A further 
precaution of measuring the blood glucose after a relaxation session, before leaving the 
therapist’s office, is also recommended to avoid the risk of hypoglycaemia while travelling 
home. 
Several studies have reported some success with improvements in diabetes control following 
relaxation training (sometimes involving EMG biofeedback) in people with Type 1 diabetes. 
There is evidence to suggest that relaxation training is least useful for those people whose 
glycaemic control is good to start with and most useful when used by people who not only 
have poor control of their diabetes but who feel that stress disrupts their diabetes control and 
who are currently experiencing stressful events. Although some studies have found no 
significant differences between relaxation and control groups in HbA1c levels or insulin 
requirements after relaxation training, information about the variability of the individual 
patients was rarely reported. In addition, lack of selection of patients likely to benefit from 
relaxation training may be responsible for the nonsignificant findings of some studies.  
What is emerging from the studies of relaxation training in people with Type 1 diabetes, is 
that it is most demonstrably useful for those who are showing stress-related disturbance of 
blood glucose control at the time. Assessment of patients’ stress-reactivity before embarking 
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on relaxation training in future studies will help in the identification of patients most likely to 
show benefit from relaxation training. To date, most studies have incorporated biofeedback 
into the relaxation training. Relaxation instructions alone would be more practical and less 
costly. Evaluation of low-technology forms of relaxation training with patients shown to be 
stress reactive would be a useful contribution to the state of present research. Such evaluation 
needs to take account of the fact that the benefits of relaxation training for blood glucose 
control will only be apparent during periods of stress when stress-reactive relaxation-trained 
individuals would be expected to have more stable blood glucose control than stress-reactive 
individuals who have not been trained. Improvements in blood glucose control will be more 
apparent if recruitment to such a study is restricted to individuals who show increased blood 
glucose under stress. 
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